Vaishali Pharma — 360° view

Vaishali Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹23 crore and net profit of ₹1.49 crore for the June 2026 quarter.

Vaishali Pharma (NSE: VAISHALI) closed at ₹6.63 on 20 Nov 2026. Its market capitalisation is ₹90 crore and it trades at 21.1 times earnings.

Share price
₹6.63 (20 Nov 2026)
Market cap
₹90 Cr (20 Nov 2026)
P/E
21.11 (20 Nov 2026)
Revenue
₹23 Cr (June 2026 quarter)
Net profit
₹1 Cr (June 2026 quarter)
ROCE
8.93% (FY26)
ROE
6.02% (FY26)
Book value
₹5.29 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹9.42 / ₹6.35 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: VAISHALI

Incorporated in 1989, Vaishali Pharma Ltd does marketing of pharmaceutical products including active pharmaceutical ingredients

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.